These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

485 related articles for article (PubMed ID: 34884651)

  • 21. Considering gut microbiota in treatment of type 2 diabetes mellitus.
    Adeshirlarijaney A; Gewirtz AT
    Gut Microbes; 2020 May; 11(3):253-264. PubMed ID: 32005089
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Targeting gut microbiota as a possible therapy for diabetes.
    He C; Shan Y; Song W
    Nutr Res; 2015 May; 35(5):361-7. PubMed ID: 25818484
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Branched chain and aromatic amino acids change acutely following two medical therapies for type 2 diabetes mellitus.
    Walford GA; Davis J; Warner AS; Ackerman RJ; Billings LK; Chamarthi B; Fanelli RR; Hernandez AM; Huang C; Khan SQ; Littleton KR; Lo J; McCarthy RM; Rhee EP; Deik A; Stolerman E; Taylor A; Hudson MS; Wang TJ; Altshuler D; Grant RW; Clish CB; Gerszten RE; Florez JC
    Metabolism; 2013 Dec; 62(12):1772-8. PubMed ID: 23953891
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective.
    Han JL; Lin HL
    World J Gastroenterol; 2014 Dec; 20(47):17737-45. PubMed ID: 25548472
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Probiotics, prebiotics, synbiotics and insulin sensitivity.
    Kim YA; Keogh JB; Clifton PM
    Nutr Res Rev; 2018 Jun; 31(1):35-51. PubMed ID: 29037268
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gut microbiota-derived metabolites as key actors in type 2 diabetes mellitus.
    Du L; Li Q; Yi H; Kuang T; Tang Y; Fan G
    Biomed Pharmacother; 2022 May; 149():112839. PubMed ID: 35325852
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pharmacologic and Nonpharmacologic Therapies for the Gut Microbiota in Type 2 Diabetes.
    Caesar R
    Can J Diabetes; 2019 Apr; 43(3):224-231. PubMed ID: 30929665
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Probiotics for pancreatic β-cell function: from possible mechanism of action to assessment of effectiveness.
    Kobyliak N; Khomenko M; Falalyeyeva T; Fedchenko A; Savchuk O; Tseyslyer Y; Ostapchenko L
    Crit Rev Microbiol; 2024 Sep; 50(5):663-683. PubMed ID: 37705353
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Gut Microbiota as the Link between Elevated BCAA Serum Levels and Insulin Resistance.
    Gojda J; Cahova M
    Biomolecules; 2021 Sep; 11(10):. PubMed ID: 34680047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Role of gut microbiota in type 2 diabetes pathophysiology.
    Gurung M; Li Z; You H; Rodrigues R; Jump DB; Morgun A; Shulzhenko N
    EBioMedicine; 2020 Jan; 51():102590. PubMed ID: 31901868
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Angelica polysaccharides relieve blood glucose levels in diabetic KKAy mice possibly by modulating gut microbiota: an integrated gut microbiota and metabolism analysis.
    Tang X; Yang L; Miao Y; Ha W; Li Z; Mi D
    BMC Microbiol; 2023 Oct; 23(1):281. PubMed ID: 37784018
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The gut microbiome as a target for prevention and treatment of hyperglycaemia in type 2 diabetes: from current human evidence to future possibilities.
    Brunkwall L; Orho-Melander M
    Diabetologia; 2017 Jun; 60(6):943-951. PubMed ID: 28434033
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gut Microbiota and Gestational Diabetes Mellitus: A Review of Host-Gut Microbiota Interactions and Their Therapeutic Potential.
    Hasain Z; Mokhtar NM; Kamaruddin NA; Mohamed Ismail NA; Razalli NH; Gnanou JV; Raja Ali RA
    Front Cell Infect Microbiol; 2020; 10():188. PubMed ID: 32500037
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Reconstruction of intestinal microecology of type 2 diabetes by fecal microbiota transplantation: Why and how.
    Hou K; Zhang S; Wu Z; Zhu D; Chen F; Lei ZN; Liu W; Xiao C; Chen ZS
    Bosn J Basic Med Sci; 2022 Jun; 22(3):315-325. PubMed ID: 34761734
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Impact of Gut Microbiota on Obesity, Diabetes, and Cardiovascular Disease Risk.
    Miele L; Giorgio V; Alberelli MA; De Candia E; Gasbarrini A; Grieco A
    Curr Cardiol Rep; 2015 Dec; 17(12):120. PubMed ID: 26497040
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Portulaca oleracea L. Extract Alleviated Type 2 Diabetes Via Modulating the Gut Microbiota and Serum Branched-Chain Amino Acid Metabolism.
    Bao M; Hou K; Xin C; Zeng D; Cheng C; Zhao H; Wang Z; Wang L
    Mol Nutr Food Res; 2022 Jun; 66(11):e2101030. PubMed ID: 35212446
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Do Probiotics Improve the Health Status of Individuals with Diabetes Mellitus? A Review on Outcomes of Clinical Trials.
    Kesika P; Sivamaruthi BS; Chaiyasut C
    Biomed Res Int; 2019; 2019():1531567. PubMed ID: 31950031
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Effect of Natural Soluble Polysaccharides on the Type 2 Diabetes through Modulating Gut Microbiota: A Review.
    Yang L; Li L; Wu X; Cai W; Lin Q; Zhu D; Liu H
    Curr Med Chem; 2021; 28(26):5368-5385. PubMed ID: 33687877
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Probiotics and Prebiotics as Dietary Supplements for the Adjunctive Treatment of Type 2 Diabetes.
    Wang Y; Wen L; Tang H; Qu J; Rao B
    Pol J Microbiol; 2023 Mar; 72(1):3-9. PubMed ID: 36929892
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Gut Microbiota and Nutrition: Strategies for the Prevention and Treatment of Type 2 Diabetes.
    Sastre M; Cimbalo A; Mañes J; Manyes L
    J Med Food; 2024 Feb; 27(2):97-109. PubMed ID: 38381517
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 25.